Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis
- PMID: 31139980
- DOI: 10.1007/s00464-019-06781-3
Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis
Abstract
Background: Several studies have been conducted comparing laparoscopic liver resection (LLR) versus open liver resection (OLR) for hepatocellular carcinoma (HCC), however, the optimal therapeutic approach has not been established. Therefore, we conducted a systematic review and meta-analysis of studies comparing LLR versus OLR for HCC.
Methods: MEDLINE and Cochrane Central Register of Controlled Trials database were systematically searched for relevant studies.
Results: Fifty-one studies were identified including a total of 6812 patients (2786 patients underwent LLR and 4026 patients were subjected to OLR). Blood transfusion rate, hospital stay in days, 30-days mortality rate and morbidity were significantly lower in LLR comparing with OLR (odds ratio (OR) 0.45; 95% confidence interval (CI) 0.30-0.69; P = 0.001; I2 = 55.83%), (MD - 3.87; 95% CI - 4.86 to - 2.89; P = 0.001; I2 = 87.35%), (OR 0.32; 95% CI 0.16-0.66; P = 0.001; I2 = 0%), and (OR 0.42; 95% CI 0.34-0.52; P = 0.001; I2 = 39.64), respectively. There was no significant difference between LLR and OLR regarding the operative time in minutes, resection margin in centimeter and R0 resection (MD 18.29; 95% CI - 1.58 to 38.15; p = 0.07; I2 = 91.73%), (MD 0.04; 95% CI - 0.06 to 0.14; P = 0.41; I2 = 48.03%) and (OR 1.31; 95% CI 0.98-1.76; P = 0.07; I2 = 0%), respectively. The 1-year overall survival (1-OS) and 5-OS rates were significantly higher in LLR comparing with OLR (OR 1.45; 95% CI 1.06-1.99; P = 0.02; I2 = 25.59%) and (OR 1.36; 95% CI 1.07-1.72; P = 0.01; I2 = 14.88%), respectively.
Conclusion: LLR is superior to OLR regarding intraoperative blood loss, blood transfusion rate, hospital stay in days, 30-days mortality and morbidity, however, randomized controlled trials are needed to identify the superiority of either strategy.
Keywords: Carcinoma; Hepatectomy; Hepatocellular; Laparoscopy; Liver neoplasms.
Similar articles
-
Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.World J Gastroenterol. 2012 Dec 7;18(45):6657-68. doi: 10.3748/wjg.v18.i45.6657. World J Gastroenterol. 2012. PMID: 23236242 Free PMC article.
-
Laparoscopic Versus Open Hepatic Resection for Solitary Hepatocellular Carcinoma Less Than 5 cm in Cirrhotic Patients: A Randomized Controlled Study.J Laparoendosc Adv Surg Tech A. 2018 Mar;28(3):302-310. doi: 10.1089/lap.2017.0518. Epub 2017 Nov 27. J Laparoendosc Adv Surg Tech A. 2018. PMID: 29172949 Clinical Trial.
-
Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study.Surg Endosc. 2024 Jul;38(7):3887-3904. doi: 10.1007/s00464-024-10937-1. Epub 2024 Jun 3. Surg Endosc. 2024. PMID: 38831217
-
A meta-analysis: laparoscopic versus open liver resection for large hepatocellular carcinoma.Minim Invasive Ther Allied Technol. 2025 Feb;34(1):24-34. doi: 10.1080/13645706.2024.2334762. Epub 2024 Apr 18. Minim Invasive Ther Allied Technol. 2025. PMID: 38634257 Review.
-
Meta-analysis of laparoscopic versus open resection for hepatocellular carcinoma.Dig Dis Sci. 2011 Jul;56(7):1937-43. doi: 10.1007/s10620-011-1572-7. Epub 2011 Jan 23. Dig Dis Sci. 2011. PMID: 21259071 Review.
Cited by
-
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study.Hepatol Int. 2023 Oct;17(5):1251-1264. doi: 10.1007/s12072-023-10492-2. Epub 2023 Apr 15. Hepatol Int. 2023. PMID: 37060489
-
Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis.Cancers (Basel). 2023 Feb 12;15(4):1179. doi: 10.3390/cancers15041179. Cancers (Basel). 2023. PMID: 36831521 Free PMC article. Review.
-
Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma.Turk J Surg. 2024 Mar 23;40(1):1-10. doi: 10.47717/turkjsurg.2024.6375. eCollection 2024 Mar. Turk J Surg. 2024. PMID: 39036000 Free PMC article. Review.
-
Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data.Hepatol Int. 2021 Oct;15(5):1215-1235. doi: 10.1007/s12072-021-10219-1. Epub 2021 Jul 13. Hepatol Int. 2021. PMID: 34258665
-
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.BMC Gastroenterol. 2020 Aug 3;20(1):251. doi: 10.1186/s12876-020-01391-z. BMC Gastroenterol. 2020. PMID: 32746786 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical